Indiana University

How can stem cells revolutionize cancer treatments?

views 891
Air date: August 12, 2012

Host: David Crabb, MD

Cancer Healthcare Policy & Public Health Research
Email Email
Share Sound Medicine Share this segment
MP3 download Download MP3

Interview: Michael Clarke, M.D., associate director of the Stanford Institute for Stem Cell and Regenerative Medicine.



In his research at the Stanford Institute for Stem Cell and Regenerative Medicine, Michael Clarke, M.D., has isolated a type of cancer cell that is capable of producing new tumors because of its stem-cell-like behavior. This discovery has the potential to change the way certain types of cancer are treated, by targeting only the cancer cells that have the stem-cell-like behavior. Clarke, associate director of the Stanford Institute for Stem Cell and Regenerative Medicine and an alumnus of IU, was the keynote speaker at this year’s Cancer Research Day at IUSM. This week on “Sound Medicine,” Clarke shares the background behind the relationship between stem and cancer cells and the aptitude that stem-cell-like cancer cells have for creating better treatments.

Find us on:

Sound Medicine facebook fan page Follow Sound Medicine on twitter

Listen to us free at:

Sound Medicine on Stitcher

Promo code: Sound